Arrowhead Pharmaceuticals Inc (ARWR) FY2025Q3 Earning Prediction
Arrowhead Pharmaceuticals Inc (ARWR) is set to release its earnings performance on 08/07 16:01:00 ET in After Hours trading. Consensus forecasts predict a revenue of 29.01M and an earnings per share (EPS) of -0.94 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
ARWR Transcript
The earnings call reveals strong financial performance, with a significant increase in net income and revenue driven by collaboration agreements. Product development updates, including the commercial launch of REDEMPLO and partnerships with Novartis and Sarepta, are promising. However, management's avoidance of specific questions in the Q&A might cause slight concern. The market cap suggests moderate volatility, leading to a positive stock price movement prediction of 2% to 8% over the next two weeks.
The earnings call highlights strong financial performance, strategic partnerships, and promising product development, such as the plozasiran launch and multiple drug pipelines. Despite some uncertainties in clinical trial outcomes and regulatory claims, the overall sentiment remains positive due to solid financial health, strategic partnerships, and optimistic guidance. The market cap suggests a moderate reaction, likely resulting in a positive stock price movement of 2% to 8% over the next two weeks.
ARWR Report
Frequently Asked Questions
What is the Arrowhead Pharmaceuticals Inc FY2025Q3 Earnings Release Date and Time?
Arrowhead Pharmaceuticals Inc (ARWR) is scheduled to release its FY2025Q3 earnings report onAug 7, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Arrowhead Pharmaceuticals Inc FY2025Q3 Revenue and EPS?
Analysts' consensus predicts 29.01M in revenue and an EPS of -0.94 for Arrowhead Pharmaceuticals Inc's FY2025Q3.
What Does Intellectia's AI Predict for Arrowhead Pharmaceuticals Inc FY2025Q3 Earnings?
Intellectia's exclusive AI algorithms forecast a forArrowhead Pharmaceuticals Inc's FY2025Q3 earnings, with a prediction date of Aug 7, 2025. Arrowhead Pharmaceuticals Inc
How Can I Use This Earnings Prediction to Trade ARWR Stock?
Leverage Intellectia's AI forecast to position trades ahead of theAug 7, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Arrowhead Pharmaceuticals Inc FY2025Q3?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
